Article Text

Download PDFPDF
CASE REPORT
Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer
  1. Scott L Purga1,
  2. Navneet Narula2,
  3. Evelyn M Horn3,
  4. Maria G Karas3
  1. 1Department of Internal Medicine, NYP/Weill Cornell Medical College, New York, New York, USA
  2. 2Department of Pathology, Weill Cornell Medical College, New York, New York, USA
  3. 3Department of Cardiology, Weill Cornell Medical College, New York, New York, USA
  1. Correspondence to Dr Scott L Purga, scottpurga{at}gmail.com

Summary

A 78-year-old woman with metastatic low-grade serous ovarian cancer presented with rapidly progressive exertional dyspnoea and hypoxia, and was found to have new-onset severe pulmonary hypertension (PH) by right heart catheterisation. A diagnosis of pulmonary tumour thrombotic microangiopathy (PTTM) was made at autopsy. PTTM is a rare complication of advanced cancer that often presents as rapidly progressive PH or acute hypoxic respiratory failure. Widespread tumour cell emboli in the pulmonary arteries and arterioles are hypothesised to induce fibrocellular subintimal proliferation and microthrombi, leading to increased pulmonary vascular resistance and PH. PTTM arising from serous ovarian cancer is exceedingly rare, with only two previously reported cases. A discussion of the pathophysiology, diagnosis and management of PTTM is presented.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.